rdf:type |
|
lifeskim:mentions |
umls-concept:C0003762,
umls-concept:C0004096,
umls-concept:C0038317,
umls-concept:C0205419,
umls-concept:C0243192,
umls-concept:C0332281,
umls-concept:C0439793,
umls-concept:C0871261,
umls-concept:C1417683,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-11
|
pubmed:abstractText |
Arginase probably plays an important role in asthma development, severity and progression. Polymorphisms in arginase 1 and arginase 2 genes have been associated with childhood asthma and FEV1 reversibility to beta2 agonists.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1744-6880
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
179-86
|
pubmed:meshHeading |
pubmed-meshheading:20124949-Adrenergic beta-Agonists,
pubmed-meshheading:20124949-Adult,
pubmed-meshheading:20124949-Anti-Asthmatic Agents,
pubmed-meshheading:20124949-Arginase,
pubmed-meshheading:20124949-Asthma,
pubmed-meshheading:20124949-Cohort Studies,
pubmed-meshheading:20124949-Humans,
pubmed-meshheading:20124949-Isoenzymes,
pubmed-meshheading:20124949-Longitudinal Studies,
pubmed-meshheading:20124949-Pharmacogenetics,
pubmed-meshheading:20124949-Polymorphism, Genetic,
pubmed-meshheading:20124949-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Arginase 1 and arginase 2 variations associate with asthma, asthma severity and beta2 agonist and steroid response.
|
pubmed:affiliation |
Department of Epidemiology, University Medical Center Groningen, The Netherlands. j.m.vonk@epi.umcg.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|